A serum vitamin B12 test comes back inside the reference range, and the conversation usually ends there. The number reads normal, so B12 gets crossed off the list of possible explanations for the fatigue, the tingling in the hands, the brain fog that will not lift. But laboratory medicine treats that conversation as unfinished. There is a second marker that can catch a vitamin B12 problem the standard test misses: methylmalonic acid, or MMA.
What MMA actually is
Methylmalonic acid is a byproduct made in small amounts as the body digests certain proteins and fats, part of ordinary metabolism. The connection to B12 comes down to a single enzyme: vitamin B12 is a required cofactor for the reaction that converts MMA into a compound the body can use for energy. When B12 is scarce, that conversion slows, and MMA has nowhere to go but up. As Cleveland Clinic explains it, when a person has low levels of B12, or is not absorbing it properly, the body makes more MMA than it can break down. A high MMA reading is, in effect, a chemical trace of a stalled enzyme, one link upstream of the vitamin itself.
Why the B12 test alone can mislead
A standard serum B12 test measures how much vitamin is circulating in the blood, not how much of it the body's cells can actually use. According to the NIH Office of Dietary Supplements, most labs consider serum B12 below roughly 200 to 250 picograms per milliliter subnormal, but MMA is described as the most sensitive marker of true B12 status, with a level above about 0.271 micromoles per liter suggesting deficiency even when the B12 number itself looks acceptable. The agency is specific about where the two tests intersect: when serum B12 falls into a gray zone of roughly 150 to 399 picograms per milliliter, checking MMA is the recommended way to confirm whether a real deficiency is present. Cleveland Clinic frames the practical version plainly: a patient can have a normal B12 result and an elevated MMA at the same time, and that combination can still point to an early or mild deficiency, especially with symptoms present.
This is not a hypothetical edge case. The same NIH fact sheet notes that low or marginal B12 status, a level between 200 and 300 picograms per milliliter without classic anemia or nerve symptoms, is common in Western populations, affecting up to roughly 40 percent of some study samples. Separate NHANES-based estimates put outright B12 insufficiency, below 300 picograms per milliliter, at about 12.5 percent of American adults 19 and older, most of whom will never be flagged by a B12 test alone.
Reference ranges vary by lab and sample type. Cleveland Clinic lists a typical normal blood MMA level as under 0.40 micromoles per liter, while urine MMA as high as 4.0 millimoles per mole of creatinine can still be normal. The NIH's 0.271 cutoff sits comfortably inside that broader normal band, which is exactly why interpretation depends on context rather than one hard line. MMA is rarely read alone; providers typically compare it against the B12 result and, often, a homocysteine test.
MMA versus its more famous cousin, homocysteine
Homocysteine and MMA are frequently ordered together, and both can rise when B12 runs low, but they are not interchangeable. Homocysteine is the more sensitive of the two, rising quickly as B12 status declines, yet it has poor specificity alone: it climbs with low folate, declining kidney function, and other unrelated conditions. Testing.com's FAQ on the MMA test makes the distinction that matters most: MMA metabolism depends specifically on vitamin B12, not folate, which is why MMA is typically normal in folate deficiency even though homocysteine can be elevated in both. If both markers are high, B12 is the leading suspect. If homocysteine is high but MMA is normal, folate becomes the more likely explanation.
The one confounder worth knowing
MMA is not a perfectly clean signal either. It rises with kidney disease independent of B12 status, since the kidneys clear it, and the NIH fact sheet notes that MMA also tends to run higher in older adults generally. That age effect is established enough that researchers have called for age-specific reference ranges, rather than one flat cutoff for a 30-year-old and an 80-year-old alike. A mildly elevated MMA in an older adult with reduced kidney function is read differently than the same number in a younger person with normal kidneys and a plant-based diet.
Who typically gets tested
MMA is not a population-wide screening test; its value is concentrated in specific situations. Symptoms of possible B12 deficiency prompt it most often: fatigue, tingling or numbness in the hands and feet, digestive complaints, unexplained mood changes, or loss of appetite. The groups most likely to run low on B12, per the NIH fact sheet, are largely the same groups who benefit most from MMA testing when a B12 result is ambiguous: older adults, especially those with atrophic gastritis (a condition affecting an estimated 8 to 9 percent of adults over 65 that reduces the stomach acid and intrinsic factor needed for absorption); people with pernicious anemia, an autoimmune condition estimated to affect roughly 151 per 100,000 people in the United States; people with Crohn's disease, celiac disease, or a history of gastric bypass or other GI surgery; strict vegetarians and vegans; and anyone on long-term acid-reducing medication or metformin, both documented to interfere with B12 absorption or levels. MMA is also part of routine newborn screening, where it flags methylmalonic acidemia, a rare inherited disorder unrelated to dietary B12 status.
Why the lag matters
One detail from the NIH fact sheet puts the whole picture in perspective: the body stores roughly 1 to 5 milligrams of vitamin B12, on the order of a thousand times the amount typically consumed in a single day. That reserve is exactly why B12 deficiency can take years to produce a symptom, and why a snapshot test, taken against a large buffer, can still read as normal even as the underlying supply is thinning. MMA does not eliminate that lag, but by tracking a functional consequence of low B12 rather than the circulating vitamin itself, it can pick up the shortfall earlier than waiting for the B12 number to fall low enough to trigger on its own.
The honest takeaway
Methylmalonic acid is not a replacement for a standard B12 test, and an elevated result does not by itself diagnose anything; it is a follow-up tool for a common gray zone. It earns its place when B12 sits in that borderline range, when symptoms persist despite a normal B12 result, or in one of the higher-risk groups above. Read alongside homocysteine and the clinical picture, it can turn an inconclusive B12 test into an actual answer.
Common questions
Does a normal B12 test rule out a deficiency? Not entirely. Serum B12 alone has real limitations, and MMA is the more sensitive marker; a technically normal B12 level can coexist with an elevated MMA consistent with an early or functional deficiency, particularly in the 150 to 399 picogram per milliliter gray zone.
What causes a high methylmalonic acid result besides low B12? Kidney disease is the main confounder, since impaired kidney function lets MMA accumulate independent of vitamin status. MMA also tends to run higher in older adults generally, and it is separately used to screen newborns for methylmalonic acidemia, a rare inherited disorder unrelated to diet.
Why order both MMA and homocysteine? Homocysteine is sensitive but rises with low folate and declining kidney function too, so it lacks specificity alone. MMA is more specific to B12. A high MMA with a high homocysteine points at B12; a normal MMA with a high homocysteine points toward folate.
Should everyone get this on a routine panel? No. It is a targeted follow-up, not a population screen: borderline B12 results, persistent symptoms despite normal B12, elevated-risk groups such as older adults, strict vegetarians and vegans, and people with pernicious anemia or GI absorption disorders, plus standard newborn screening.
How is the test performed? Most commonly a blood draw, similar to any standard lab test, sometimes requiring a few hours of fasting beforehand. A urine version also exists and is used more often to confirm an elevated blood result or monitor infants with methylmalonic acidemia.
